Cargando…

1743. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality within the First Year after Kidney Transplantation: An Analysis of the National Transplant Registry

BACKGROUND: Cytomegalovirus (CMV) infection is one of the leading causes of morbidity and mortality in kidney transplant (KT) recipients. We investigated the association of CMV serostatus and allograft outcome within the first year after KT. METHODS: All KT recipients from 2007 to 2017 were derived...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruminhent, Jackrapong, Dajsakdipon, Thanate, Watcharananan, Siriorn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808728/ http://dx.doi.org/10.1093/ofid/ofz360.1606

Ejemplares similares

168. Epidemiology, Risk Factors and Outcome of Bloodstream Infection Within the First Year After Kidney Transplantation
por: Siritip, Napadol, et al.
Publicado: (2019)

Epidemiology and Outcomes of Early-Onset and Late-Onset Adenovirus Infections in Kidney Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

2508. Absolute Lymphocyte Count and Adenovirus-Specific CD8+ T-cell Immunity as Immunological Predictors of Severe Adenovirus Disease After Kidney Transplantation
por: Bruminhent, Jackrapong, et al.
Publicado: (2018)

BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: A retrospective cohort study
por: Chitasombat, Maria N., et al.
Publicado: (2018)

Association Between Cytomegalovirus Serostatus, Antiviral Therapy, and Allograft Survival in Pediatric Heart Transplantation
por: Rabbani, Naveed, et al.
Publicado: (2022)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

1749. A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Cytomegalovirus Serostatus and Functional Impairment in Liver Transplant Recipients in the Current Era
por: Singh, Nina, et al.
Publicado: (2021)

BK Virus and Cytomegalovirus Coinfections in Kidney Transplantation and Their Impact on Allograft Loss
por: Herrera, Sabina, et al.
Publicado: (2021)

509. Role of cell-mediated immune monitoring using Interferon-γ Enzyme-linked Immunosorbent Spot Assay to predict CMV infection within six months after kidney transplantation
por: Namsiripongpan, Warunyu, et al.
Publicado: (2022)

Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes
por: Cohen, Jordana B., et al.
Publicado: (2017)

1189. Correlation of BK polyomavirus (BKPyV)-specific Immunity and BKPyV Viruria within 6 months after Kidney Transplantation: A Prospective Cohort Study
por: Siripoon, Tanaya, et al.
Publicado: (2020)

Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients
por: Magua, Wairimu, et al.
Publicado: (2022)

Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients
por: Law, Jonathan P., et al.
Publicado: (2021)

A family cluster of diagnosed coronavirus disease 2019 (COVID‐19) kidney transplant recipient in Thailand
por: Sakulkonkij, Parichart, et al.
Publicado: (2020)

The Health of Thomas Jefferson (1743—1826)
por: Thould, A. K.
Publicado: (1989)

Impact of Carbapenem Peri-Transplant Prophylaxis and Risk of Extended-Spectrum Cephalosporin-Resistant Enterobacterales Early Urinary Tract Infection in Kidney Transplant Recipients: A Propensity Score-Matched Analysis
por: Aramwittayanukul, Suwadee, et al.
Publicado: (2022)

Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
por: Sripongpun, Pimsiri, et al.
Publicado: (2022)

1183. A Prospective Epidemiological & Immunological Study of Cytomegalovirus infection in SLE Patients Receiving Immunosuppressant
por: Autto, Suphanan, et al.
Publicado: (2020)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Clinical and immunological characteristics for BK polyomavirus‐associated nephropathy after kidney transplantation
por: Siripoon, Tanaya, et al.
Publicado: (2023)

The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2018)

431 Incidence, Burden and Cost Analysis of CMV Reactivation after Use of Anti-Thymocyte Globulin in Resource-Limited Setting
por: Chitasombat, Maria N., et al.
Publicado: (2014)

A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants
por: Bruminhent, Jackrapong, et al.
Publicado: (2021)

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus on Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
por: El-Cheikh, Jean, et al.
Publicado: (2013)

Meniscal Allograft Transplantation With Concomitant Osteochondral Allograft Transplantation
por: Cotter, Eric J., et al.
Publicado: (2017)

2655. A Prospective Study of Cytomegalovirus Infection in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Epidemiology, Associated Risk Factors, Pathogenesis, and Clinical Outcomes
por: Bushyakanist, Asalaysa, et al.
Publicado: (2019)

The Kidney Failure Risk Equation for Prediction of Allograft Loss in Kidney Transplant Recipients
por: Chu, Chi D., et al.
Publicado: (2020)

1743 Racial Disparities Among Tuberculosis Deaths in the United States, 1999-2009
por: Chaudhari, Shilpa, et al.
Publicado: (2014)

Pre-Transplantation Assessment of BK Virus Serostatus: Significance, Current Methods, and Obstacles
por: Dakroub, Fatima, et al.
Publicado: (2019)

494. Real-world effectiveness of tixagevimab/cilgavimab for COVID-19 pre-exposure prophylaxis in solid organ transplant recipients during the Omicron variant period
por: Rojanakit, Gun, et al.
Publicado: (2023)

Clinical outcome of rapid diagnosis and antibiotic stewardship in patients with bloodstream infection in Lampang Hospital
por: Sakulkonkij, Parichart, et al.
Publicado: (2022)

Allograft loss from acute Page kidney secondary to trauma after kidney transplantation
por: Takahashi, Kazuhiro, et al.
Publicado: (2017)

Feature Importance of Acute Rejection among Black Kidney Transplant Recipients by Utilizing Random Forest Analysis: An Analysis of the UNOS Database
por: Thongprayoon, Charat, et al.
Publicado: (2021)

Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients
por: Hughes, David, et al.
Publicado: (2008)

Toxoplasma gondii Serostatus Is Not Associated With Impaired Long-Term Survival after Heart Transplantation
por: van Hellemond, Jaap J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_np38jpul96r4ib4m50ruadbbcv